Treatment with the nitric oxide synthase inhibitor L-NAME provides a survival advantage in a mouse model of Kras mutation-positive, non-small cell lung cancer

av Pershing, Nicole L.K., Yang, Chi-Fu J., Xu, MengMeng, Counter, Christopher M.
I publikationen Oncotarget (2016)

The Role of Adjuvant Therapy in Patients with Margin-Positive (R1) Esophagectomy: A National Analysis

av Raman, Vignesh, Jawitz, Oliver K., Voigt, Soraya L., Yang, Chi-Fu J., D’Amico, Thomas A., Harpole, David H.
I publikationen J Surg Res (2020)

Effect of Time to Surgery on Outcomes in Stage I Esophageal Adenocarcinoma

av Raman, Vignesh, Jawitz, Oliver K., Voigt, Soraya L., Yang, Chi-Fu J., Wang, Hanghang, Harpole, David H., D’Amico, Thomas A.
I publikationen J Thorac Cardiovasc Surg (2019)

Surgery is Associated with Survival Benefit in T4a Esophageal Adenocarcinoma: A National Analysis

av Raman, Vignesh, Jawitz, Oliver K., Voigt, Soraya L., Farrow, Norma E., Yang, Chi-Fu J., D’Amico, Thomas A., Harpole, David H.
I publikationen Ann Thorac Surg (2019)

Adjuvant Therapy for Patients with Early Large Cell Lung Neuroendocrine Cancer: A National Analysis

av Raman, Vignesh, Jawitz, Oliver K., Yang, Chi-Fu J., Tong, Betty C., D’Amico, Thomas A., Berry, Mark F., Harpole, David H.
I publikationen Ann Thorac Surg (2019)

Outcomes for Surgery in Large Cell Lung Neuroendocrine Cancer: A National Analysis

av Raman, Vignesh, Jawitz, Oliver K., Yang, Chi-Fu J., Voigt, Soraya L., Tong, Betty C., D’Amico, Thomas A., Harpole, David H.
I publikationen J Thorac Oncol (2019)

The Effect of Age on Survival Following Endoscopic Resection vs. Surgery for T1a Esophageal Cancer

av Raman, Vignesh, Jawitz, Oliver K., Voigt, Soraya L., Yang, Chi-Fu J., Harpole, David H., D’Amico, Thomas A., Hartwig, Matthew G.
I publikationen J Thorac Cardiovasc Surg (2019)

The Effect of Extent of Resection on Outcomes in Patients with Limited Stage Small Cell Lung Cancer

av Raman, Vignesh, Jawitz, Oliver K., Yang, Chi-Fu J., Voigt, Soraya L., D’Amico, Thomas A., Harpole, David H., Tong, Betty C.
I publikationen J Thorac Cardiovasc Surg (2020)

Outcomes of Surgery vs. Chemoradiotherapy in Patients with Clinical or Pathologic N3 Non-Small Cell Lung Cancer

av Raman, Vignesh, Jawitz, Oliver K., Yang, Chi-Fu J., Voigt, Soraya L., Wang, Hanghang, D’Amico, Thomas A., Harpole, David H., Tong, Betty C.
I publikationen J Thorac Cardiovasc Surg (2019)

The Impact of Adjuvant Therapy on Survival in Patients with Indeterminate Margins Following Surgery for Non-small Cell Lung Cancer

av Raman, Vignesh, Jawitz, Oliver K., Yang, Chi-Fu J., Voigt, Soraya L., Kim, Anthony W., Tong, Betty C., D’Amico, Thomas A., Harpole, David H.
I publikationen J Thorac Cardiovasc Surg (2019)

Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non-Small Cell Lung Cancer

av Speicher, Paul J., Fitch, Zachary W., Gulack, Brian C., Yang, Chi-Fu J., Tong, Betty C., Harpole, David H., D'Amico, Thomas A., Berry, Mark F., Hartwig, Matthew G.
I publikationen Ann Thorac Surg (2016)

The Relationship between Lymph Node Ratio and Survival Benefit with Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma

av Raman, Vignesh, Jawitz, Oliver K., Farrow, Norma E., Voigt, Soraya L., Rhodin, Kristen E., Yang, Chi-Fu J., Turner, Megan C., D’Amico, Thomas A., Harpole, David H., Tong, Betty C.
I publikationen Ann Surg (2022)